ArticleGates open research2026
Leave no one behind: Global Analysis on monitoring childhood vaccination timeliness and catch-up using data from the WHO/UNICEF joint reporting form on Immunization.
Article in Gates open research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Recording vaccine doses administered: A global analysis of tally sheet design for infant and child immunizations.PLOS global public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
In the years following the Covid-19 pandemic, immunization programmes have increasingly focused on the capacity to conduct and monitor catch-up vaccination-for doses administered later than the recommended schedule. However, it is unclear whether information systems are able to monitor delayed vaccination. We analyzed WHO/UNICEF Joint Reporting Form data from 194 countries (2016-2022) to understand if systems for tracking delayed childhood vaccination are available and quantify catch-up doses of the first dose of a measles-containing vaccine (MCV1). For Latin American and Caribbean countries, we also explored data for the third dose of diphtheria-tetanus-pertussis vaccine (DTP3). We assessed the completeness and consistency of reporting, the proportion of delayed doses, and vaccination coverage considering both timely and delayed administration. Analyses were disaggregated by WHO Region, World Bank income classification, and Gavi support eligibility. Results show substantial variability across regions and income groups in countries' ability to capture delayed doses. Between 2016 and 2022, the proportion of countries reporting a system to record delayed doses ranged from 55.5% to 64.4% annually, with the Region of the Americas (AMR) consistently reporting a higher proportion (77.1%-82.9%). Among countries with available data, the median proportion of delayed MCV1 doses was 4.4%, suggesting that including catch-up doses in cohort monitoring would increase reported coverage by approximately 4 percentage points. This increase was smaller in Gavi-eligible countries compared with non-eligible countries. The study summarizes global differences in information systems to monitor catch-up vaccination, presents examples of cohort coverage monitoring and illustrates the need to further improve immunization information systems and explore the potential for improving vaccination coverage and population immunity through catch-up activities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.